Correlation Between Vita Coco and Orchestra BioMed

Can any of the company-specific risk be diversified away by investing in both Vita Coco and Orchestra BioMed at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vita Coco and Orchestra BioMed into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vita Coco and Orchestra BioMed Holdings, you can compare the effects of market volatilities on Vita Coco and Orchestra BioMed and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vita Coco with a short position of Orchestra BioMed. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vita Coco and Orchestra BioMed.

Diversification Opportunities for Vita Coco and Orchestra BioMed

0.15

Correlation Coefficient

Vita Coco  Orchestra BioMed

Average diversification

The 3 months correlation between Vita and Orchestra is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Vita Coco and Orchestra BioMed Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orchestra BioMed Holdings and Vita Coco is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vita Coco are associated (or correlated) with Orchestra BioMed. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orchestra BioMed Holdings has no effect on the direction of Vita Coco i.e., Vita Coco and Orchestra BioMed go up and down completely randomly.

Pair Corralation between Vita Coco and Orchestra BioMed

Given the investment horizon of 90 days Vita Coco is expected to generate 0.44 times more return on investment than Orchestra BioMed. However, Vita Coco is 2.29 times less risky than Orchestra BioMed. It trades about 0.2 of its potential returns per unit of risk. Orchestra BioMed Holdings is currently generating about -0.03 per unit of risk. If you would invest  2,831  in Vita Coco on September 30, 2024 and sell it today you would earn a total of  803.00  from holding Vita Coco or generate 28.36% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Vita Coco  vs.  Orchestra BioMed Holdings

Vita Coco

Risk-Adjusted Performance

15 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Vita Coco are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of very abnormal fundamental indicators, Vita Coco displayed solid returns over the last few months and may actually be approaching a breakup point.

Orchestra BioMed Holdings

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Orchestra BioMed Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's forward indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Pair Trading with Vita Coco and Orchestra BioMed

The main advantage of trading using opposite Vita Coco and Orchestra BioMed positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vita Coco position performs unexpectedly, Orchestra BioMed can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orchestra BioMed will offset losses from the drop in Orchestra BioMed's long position.

The idea behind Vita Coco and Orchestra BioMed Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.